Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Zomedica Corp ZOM

Healthcare Medical Devices
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:ZOM)

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024

Accesswire 10 days ago

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity

Accesswire April 1, 2024

Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET

Accesswire March 20, 2024

Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET

Accesswire March 20, 2024

Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform

Accesswire March 14, 2024

Zomedica Provides NYSE American Listing Update

Accesswire March 13, 2024

Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences

Accesswire March 12, 2024

Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs

Accesswire March 7, 2024

Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024

Accesswire March 5, 2024
View More News ››

Opinion & Analysis (NYSEAM:ZOM)

Pet Cancer Diagnostics? An Untapped Market

Stockhouse Editorial March 19, 2018

Exciting animal health niche offers diversification opportunity

Stockhouse Editorial March 22, 2017

ZoMedica (V.ZOM) to seize multi-billion companion pet health space through innovation

Gaalen Engen April 14, 2016
View More Opinion ››

Bullboard Posts (NYSEAM:ZOM)

Zomedica to Present at the Noble Capital Markets Virtual Hea

JUST IN: $ZOM Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024ANN ARBOR, MI / ACCESSWIRE...
whytestocks - 9 days ago

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Jannine - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
Jannine - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Jannine - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

Jannine - June 2, 2022

check out nirvana life sciences

newly listed Canadian company $nirv listing on the u.s OTC soon!
theleak - May 18, 2022
View more Bullboard ››

SEGO Resources Inc

SEGO Resources Inc

SEGO Resources Inc. is a Canada-based exploration stage company. The Company is engaged in the acquisition, exploration, and ...
View More »